ACTolog 0 7 0 7 O
target 8 14 8 14 O
expression 15 25 15 25 O
as 26 28 26 28 O
evaluated 29 38 29 38 O
by 39 41 39 41 O
the 42 45 42 45 O
in 46 48 46 48 O
vitro 49 54 49 54 O
diagnostic 55 65 55 65 O
device 66 72 66 72 O
IMA_Detect 73 83 73 83 O
: 83 84 83 84 O
Patient 85 92 85 92 O
's 92 94 92 94 O
tumor 95 100 95 100 B-cancer
must 101 105 101 105 O
express 106 113 106 113 O
at 114 116 114 116 O
least 117 122 117 122 O
one 123 126 123 126 O
ACTolog 127 134 127 134 O
target 135 141 135 141 O
as 142 144 142 144 O
assessed 145 153 145 153 O
by 154 156 154 156 O
quantitative 157 169 157 169 O
PCR 170 173 170 173 O
( 174 175 174 175 O
qPCR 175 179 175 179 O
) 179 180 179 180 O
( 181 182 181 182 O
to 182 184 182 184 O
be 185 187 185 187 O
assessed 188 196 188 196 O
from 197 201 197 201 O
a 202 203 202 203 O
tumor 204 209 204 209 B-treatment
biopsy 210 216 210 216 I-treatment
to 217 219 217 219 O
be 220 222 220 222 O
performed 223 232 223 232 O
if 233 235 233 235 O
all 236 239 236 239 O
other 240 245 240 245 O
eligibility 246 257 246 257 O
criteria 258 266 258 266 O
are 267 270 267 270 O
met 271 274 271 274 O
) 274 275 274 275 O

Active 0 6 276 282 B-chronic_disease
diverticulitis 7 21 283 297 I-chronic_disease

At 0 2 298 300 O
least 3 8 301 306 O
one 9 12 307 310 O
lesion 13 19 311 317 O
( 20 21 318 319 O
metastasis 21 31 319 329 B-cancer
or 32 34 330 332 O
primary 35 42 333 340 B-cancer
tumor 43 48 341 346 I-cancer
) 48 49 346 347 O
being 50 55 348 353 O
considered 56 66 354 364 O
accessible 67 77 365 375 O
by 78 80 376 378 O
non 81 84 379 382 O
- 84 85 382 383 O
high 85 89 383 387 O
- 89 90 387 388 O
risk 90 94 388 392 O
collection 95 105 393 403 O
procedures 106 116 404 414 O
for 117 120 415 418 O
biopsy 121 127 419 425 O

Eastern 0 7 426 433 B-clinical_variable
Cooperative 8 19 434 445 I-clinical_variable
Oncology 20 28 446 454 I-clinical_variable
Group 29 34 455 460 I-clinical_variable
( 35 36 461 462 I-clinical_variable
ECOG 36 40 462 466 I-clinical_variable
) 40 41 466 467 I-clinical_variable
performance 42 53 468 479 I-clinical_variable
status 54 60 480 486 I-clinical_variable
0 61 62 487 488 B-lower_bound
- 62 63 488 489 O
1 63 64 489 490 B-upper_bound

HIV 0 3 491 494 B-chronic_disease
infection 4 13 495 504 I-chronic_disease

History 0 7 505 512 O
of 8 10 513 515 O
hypersensitivity 11 27 516 532 O
to 28 30 533 535 O
cyclophosphamide 31 47 536 552 B-allergy_name
, 47 48 552 553 O
fludarabine 49 60 554 565 B-allergy_name
or 61 63 566 568 O
IL-2 64 68 569 573 B-allergy_name

History 0 7 574 581 O
of 8 10 582 584 O
or 11 13 585 587 O
current 14 21 588 595 O
immunodeficiency 22 38 596 612 B-chronic_disease
disease 39 46 613 620 I-chronic_disease
or 47 49 621 623 O
prior 50 55 624 629 B-treatment
treatment 56 65 630 639 I-treatment
compromising 66 78 640 652 O
immune 79 85 653 659 O
function 86 94 660 668 O
at 95 97 669 671 O
the 98 101 672 675 O
discretion 102 112 676 686 O
of 113 115 687 689 O
the 116 119 690 693 O
treating 120 128 694 702 O
physician 129 138 703 712 O

History 0 7 713 720 O
of 8 10 721 723 O
other 11 16 724 729 O
malignancies 17 29 730 742 B-cancer
( 30 31 743 744 O
except 31 37 744 750 O
for 38 41 751 754 O
adequately 42 52 755 765 O
treated 53 60 766 773 O
basal 61 66 774 779 B-cancer
or 67 69 780 782 O
squamous 70 78 783 791 B-cancer
cell 79 83 792 796 I-cancer
carcinoma 84 93 797 806 I-cancer
or 94 96 807 809 O
carcinoma 97 106 810 819 B-cancer
in 107 109 820 822 I-cancer
situ 110 114 823 827 I-cancer
) 114 115 827 828 O
within 116 122 829 835 O
the 123 126 836 839 O
last 127 131 840 844 B-upper_bound
3 132 133 845 846 I-upper_bound
years 134 139 847 852 I-upper_bound

Immunosuppression 0 17 853 870 B-treatment
, 17 18 870 871 O
not 19 22 872 875 O
related 23 30 876 883 O
to 31 33 884 886 O
prior 34 39 887 892 O
treatment 40 49 893 902 O
for 50 53 903 906 O
malignancy 54 64 907 917 B-cancer

Life 0 4 918 922 B-clinical_variable
expectancy 5 15 923 933 I-clinical_variable
> 16 17 934 935 O
6 18 19 936 937 B-lower_bound
months 20 26 938 944 I-lower_bound
prior 27 32 945 950 I-lower_bound
to 33 35 951 953 O
enrollment 36 46 954 964 O

Male 0 4 965 969 B-gender
subjects 5 13 970 978 I-gender
must 14 18 979 983 O
agree 19 24 984 989 B-contraception_consent
to 25 27 990 992 I-contraception_consent
use 28 31 993 996 I-contraception_consent
effective 32 41 997 1006 I-contraception_consent
contraception 42 55 1007 1020 I-contraception_consent
or 56 58 1021 1023 O
abstinence 59 69 1024 1034 B-contraception_consent
while 70 75 1035 1040 O
on 76 78 1041 1043 O
study 79 84 1044 1049 O
and 85 88 1050 1053 O
for 89 92 1054 1057 O
90 93 95 1058 1060 B-lower_bound
days 96 100 1061 1065 I-lower_bound
after 101 106 1066 1071 O
infusion 107 115 1072 1080 B-treatment
of 116 118 1081 1083 I-treatment
the 119 122 1084 1087 I-treatment
ACTolog 123 130 1088 1095 I-treatment
T 131 132 1096 1097 I-treatment
- 132 133 1097 1098 I-treatment
cell 133 137 1098 1102 I-treatment
product 138 145 1103 1110 I-treatment

Patient 0 7 1111 1118 O
is 8 10 1119 1121 O
a 11 12 1122 1123 O
candidate 13 22 1124 1133 O
for 23 26 1134 1137 O
a 27 28 1138 1139 O
maximum 29 36 1140 1147 O
of 37 39 1148 1150 O
one 40 43 1151 1154 O
further 44 51 1155 1162 O
line 52 56 1163 1167 O
of 57 59 1168 1170 O
established 60 71 1171 1182 O
therapy 72 79 1183 1190 O
( 80 81 1191 1192 O
prior 81 86 1192 1197 O
to 87 89 1198 1200 O
treatment 90 99 1201 1210 O
with 100 104 1211 1215 O
ACTolog 105 112 1216 1223 B-treatment
) 112 113 1223 1224 O

Patients 0 8 1225 1233 O
with 9 13 1234 1238 O
brain 14 19 1239 1244 B-cancer
metastases 20 30 1245 1255 I-cancer

Patients 0 8 1256 1264 O
with 9 13 1265 1269 O
prior 14 19 1270 1275 O
stem 20 24 1276 1280 B-treatment
cell 25 29 1281 1285 I-treatment
transplantation 30 45 1286 1301 I-treatment
or 46 48 1302 1304 O
solid 49 54 1305 1310 B-treatment
organ 55 60 1311 1316 I-treatment
transplantation 61 76 1317 1332 I-treatment

Serious 0 7 1333 1340 O
autoimmune 8 18 1341 1351 B-chronic_disease
disease 19 26 1352 1359 I-chronic_disease
: 26 27 1359 1360 O
Patients 28 36 1361 1369 O
with 37 41 1370 1374 O
a 42 43 1375 1376 O
history 44 51 1377 1384 O
of 52 54 1385 1387 O
active 55 61 1388 1394 O
serious 62 69 1395 1402 O
inflammatory 70 82 1403 1415 B-chronic_disease
bowel 83 88 1416 1421 I-chronic_disease
disease 89 96 1422 1429 I-chronic_disease
( 97 98 1430 1431 O
including 98 107 1431 1440 O
Crohn 108 113 1441 1446 B-chronic_disease
's 113 115 1446 1448 I-chronic_disease
disease 116 123 1449 1456 I-chronic_disease
and 124 127 1457 1460 O
ulcerative 128 138 1461 1471 B-chronic_disease
colitis 139 146 1472 1479 I-chronic_disease
) 146 147 1479 1480 O
or 148 150 1481 1483 O
autoimmune 151 161 1484 1494 B-chronic_disease
disorders 162 171 1495 1504 I-chronic_disease
such 172 176 1505 1509 O
as 177 179 1510 1512 O
rheumatoid 180 190 1513 1523 B-chronic_disease
arthritis 191 200 1524 1533 I-chronic_disease
, 200 201 1533 1534 O
systemic 202 210 1535 1543 B-chronic_disease
progressive 211 222 1544 1555 I-chronic_disease
sclerosis 223 232 1556 1565 I-chronic_disease
[ 233 234 1566 1567 I-chronic_disease
scleroderma 234 245 1567 1578 I-chronic_disease
] 245 246 1578 1579 I-chronic_disease
, 246 247 1579 1580 O
systemic 248 256 1581 1589 B-chronic_disease
Lupus 257 262 1590 1595 I-chronic_disease
Erythematosus 263 276 1596 1609 I-chronic_disease
or 277 279 1610 1612 O
autoimmune 280 290 1613 1623 B-chronic_disease
vasculitis 291 301 1624 1634 I-chronic_disease
[ 302 303 1635 1636 O
e.g. 303 307 1636 1640 O
Wegener 308 315 1641 1648 B-chronic_disease
's 315 317 1648 1650 I-chronic_disease
Granulomatosis 318 332 1651 1665 I-chronic_disease
] 332 333 1665 1666 O
are 334 337 1667 1670 O
excluded 338 346 1671 1679 O
from 347 351 1680 1684 O
this 352 356 1685 1689 O
study 357 362 1690 1695 O

Women 0 5 1696 1701 B-gender
of 6 8 1702 1704 O
childbearing 9 21 1705 1717 O
potential 22 31 1718 1727 O
must 32 36 1728 1732 O
agree 37 42 1733 1738 B-contraception_consent
to 43 45 1739 1741 I-contraception_consent
use 46 49 1742 1745 I-contraception_consent
adequate 50 58 1746 1754 I-contraception_consent
contraception 59 72 1755 1768 I-contraception_consent
( 73 74 1769 1770 O
hormonal 74 82 1770 1778 B-contraception_consent
or 83 85 1779 1781 I-contraception_consent
barrier 86 93 1782 1789 I-contraception_consent
method 94 100 1790 1796 I-contraception_consent
of 101 103 1797 1799 I-contraception_consent
birth 104 109 1800 1805 I-contraception_consent
control 110 117 1806 1813 I-contraception_consent
; 117 118 1813 1814 O
abstinence 119 129 1815 1825 B-contraception_consent
) 129 130 1825 1826 O
prior 131 136 1827 1832 O
to 137 139 1833 1835 O
study 140 145 1836 1841 O
entry 146 151 1842 1847 O
and 152 155 1848 1851 O
for 156 159 1852 1855 O
the 160 163 1856 1859 O
duration 164 172 1860 1868 O
of 173 175 1869 1871 O
study 176 181 1872 1877 O
participation 182 195 1878 1891 O

active 0 6 1892 1898 O
Hepatitis 7 16 1899 1908 B-chronic_disease
B 17 18 1909 1910 I-chronic_disease
or 19 21 1911 1913 I-chronic_disease
C 22 23 1914 1915 I-chronic_disease
infection 24 33 1916 1925 O

gastrointestinal 0 16 1926 1942 B-chronic_disease
obstruction 17 28 1943 1954 I-chronic_disease

has 0 3 1955 1958 O
adequate 4 12 1959 1967 O
pulmonary 13 22 1968 1977 O
function 23 31 1978 1986 O
per 32 35 1987 1990 O
protocol 36 44 1991 1999 O
and 45 48 2000 2003 O
oxygen 49 55 2004 2010 B-clinical_variable
saturation 56 66 2011 2021 I-clinical_variable
> 67 68 2022 2023 O
92 68 70 2023 2025 B-lower_bound
% 70 71 2025 2026 I-lower_bound
on 72 74 2027 2029 O
room 75 79 2030 2034 O
air 80 83 2035 2038 O

have 0 4 2039 2043 O
pathologically 5 19 2044 2058 O
confirmed 20 29 2059 2068 O
advanced 30 38 2069 2077 O
/ 38 39 2077 2078 O
metastatic 39 49 2078 2088 B-cancer
cancer 50 56 2089 2095 I-cancer
prior 57 62 2096 2101 O
to 63 65 2102 2104 O
enrollment 66 76 2105 2115 O

other 0 5 2116 2121 O
known 6 11 2122 2127 O
risk 12 16 2128 2132 O
factors 17 24 2133 2140 O
for 25 28 2141 2144 O
bowel 29 34 2145 2150 B-chronic_disease
perforation 35 46 2151 2162 I-chronic_disease

pregnant 0 8 2163 2171 B-pregnancy

